EPPIC-Genentech Partnering Event: Global Perspectives for Payer Evidence and Impact on Pricing and Access
Date: May 13, 2016 @ 12:00 pm – @ 1:00 pm
Location: Genentech Campus - Building 42-1C, 455 E. Grand Avenue, South San Francisco, CA 94080
EPPIC GLOBAL Presents
A Partnering Event with Genentech
Global Perspectives for Payer Evidence and Impact on Pricing and Access
By Brian O’Shea and Jeff Hille
The global payer environment in the biopharmaceutical space is getting increasingly complex at a time when biopharmaceutical innovation is leading to unprecedented advances in treatment of difficult diseases. Regulators are increasingly more open to approving breakthrough medications, at a time when payers are struggling to manage increasingly tight budgets and growing demand for healthcare services. Brian O’Shea and Jeff Hille, from The Global Pricing and Market Access Group at Roche will discuss these challenges at a global level, and will specifically describe how these challenges are addressed in key individual countries.
About Brian
Brian is Director in the Global Pricing and Market Access group at Genentech/Roche. He leads a team of 6 international payer strategy leaders responsible for pricing and global market access for Alectinib, Zelboraf, Erivedge, Cotellic, Tecentriq and market preparation for several early molecules. In his 8+ years at Genentech/Roche, he has had a variety of leadership experiences and roles, including starting the Reimbursement Strategy Team in Managed Care and Customer Opetarions, International Payer Strategy Leader on multiple molecules including Zelboraf and Erivedge, and Channel and Access Solutions Marketing team lead. He has over 25 years of industry experience and has previously worked at GSK, Astrazeneca, and Merck.
About Jeff
Jeff is Senior International Payer Strategy leader: Oncology Pipeline in the Global Pricing and Market Access group at Genentech/Roche. He joined the company over 8 years ago and held leadership positions in the Managed Care and Customer Operations, and Health Economics and Outcomes Research groups, and as the International Payer Strategy Leader on Perjeta. Jeff has over 14 years in of industry experience and has previously worked at Eli Lilly.
About Genentech and EPPIC
Genentech, a pioneer in Biotechnology, is well known for its investment in innovation and the principles of partnering, mentoring and networking within its organization as well as the wider life sciences community.
EPPIC GLOBAL has enjoyed partner events and sponsorship support from Genentech for over a decade. In 2016, EPPIC is proud to announce that Genentech was one of the Platinum Sponsors to the annual flagship conference – EPPICon 2016. Several leaders from Genentech were at the event and many symbiotic interactions have already begun.
Come join EPPIC today!
EPPIC strives to bring its members partnering and enriching events that synergize the values and principles of the organization.
Register FREE for this event at: https://www.123signup.com/register?id=ngrjv
When: Friday, May 13, 2016 12:00 -1:00 PM
Where: Genentech Campus - Building 42-1C, 455 E. Grand Avenue, South San Francisco, CA 94080
Lunch will be provided from 11:30 onwards
Free Registration ends on Friday, May 09, 2016
.